Fluorotechnics Enters Electrophoresis Market

Fluorotechnics focuses on the development of fluorescent tools for proteomics, cell biology, and biochemistry research. The integrated company will retain its manufacturing bases in Australia and Germany. Duncan Veal will continue as CEO, Hanspeter Schickle, CEO of ETC, will become head of electrophoresis product development, and Günter Theßeling, a recent appointment from GE Healthcare, will lead the sales and marketing drive.

Sales of equipment for proteomics are increasing as more and more scientists are attempting to understand how the expression of proteins is linked with disease onset and progression. This merger combines the skills needed to label specific species and then separate them.

Fluorotechnics CEO, Duncan Veal, stated, "We are very excited by the synergies that the combination of the two companies will bring. This acquisition will allow us to cross-sell products to existing customers and to address new markets utilizing our joint expertise. Our ever-expanding sales and marketing team and enormous potential for our product offering mean that we are well positioned for strong growth.”

"We know that our customers will welcome the extended offering and complete solution that the range of Fluorotechnics and ETC products will now provide,” said Hanspeter Schickle, CEO of ETC. "The merged group possesses exceptional expertise, has a dynamic product pipeline, and is set to become a leading supplier to life-scientists, globally.”


Related Links:
Fluorotechnics
ETC Elektrophorese-Technik